Effects of neuroleptanesthesia on catecholamines.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002395:Catecholamines / Q000378:metabolism*; D002415:Cats; D003916:Dextromoramide / Q000494:pharmacology; D004285:Dogs; D004338:Drug Combinations; D004837:Epinephrine / Q000097:blood / Q000652:urine; D005283:Fentanyl / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007442:Intubation, Intratracheal / Q000009:adverse effects; D008614:Meperidine / Q000494:pharmacology; D009020:Morphine / Q000494:pharmacology; D009458:Neuroleptanalgesia; D009638:Norepinephrine / Q000652:urine; D010423:Pentazocine / Q000494:pharmacology; D013050:Spectrometry, Fluorescence; D013390:Succinylcholine / Q000494:pharmacology; D013514:Surgical Procedures, Operative; D013874:Thiopental / Q000494:pharmacology; D014403:Tubocurarine / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D002395:Catecholamines; D004338:Drug Combinations; D009020:Morphine; D008614:Meperidine; D003916:Dextromoramide; D013390:Succinylcholine; D013874:Thiopental; D010423:Pentazocine; D005283:Fentanyl; D014403:Tubocurarine; D009638:Norepinephrine; D004837:Epinephrine